N. Sato et al., Establishment of a new human pancreatic cancer cell line, NOR-P1, with high angiogenic activity and metastatic potential, CANCER LETT, 155(2), 2000, pp. 153-161
We present here a new cell line, NOR-P1. established from a metastatic subc
utaneous tumor of a patient with pancreatic cancer. The cells show rapid gr
owth in culture with a doubling time of 16 h and high migration activity. G
enetic and molecular analyses revealed high telomerase activity and a mutat
ion in the K-ras oncogene. Of particular interest, the cells express marked
ly elevated mRNA levels of angiogenic factors, vascular endothelial growth
factor and platelet-derived growth factor, as well as other tumor growth-re
lated factors. Subcutaneous transplantation of the NOR-P1 cells into nude m
ice formed solid-hemorrhagic tumors which were histologically diagnosed as
adenocarcinoma with dense blood vessels and severe extravasation of blood.
Furthermore, when NOR-P1 cell suspension was injected directly into the pan
creas of nude mice. the cells grew rapidly to form intra-pancreatic tumors
associated with liver metastases and peritoneal dissemination that resulted
in cachexia and subsequent death. These properties suggest that NOR-P1 is
an aggressive pancreatic cancer cell line with a high metastatic potential
and may serve as a useful experimental model for studying tumor angiogenesi
s and metastasis of pancreatic cancer. (C) 2000 Elsevier Science Ireland Lt
d. All rights reserved.